Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VMD-928 Monotherapy and Combination With Pembrolizumab in Solid Tumors or Lymphoma
NCT03556228Phase 2Recruiting
- Sponsor
- VM Oncology
- Start
- Jun 2018
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of VMD-928 in solid tumor, lymphoma, sponsored by VM Oncology. Started Jun 2018; status: recruiting.
02
Drugs
VMD-928
03
Conditions
solid tumorlymphoma
Beyond the preview
Go deeper on NCT03556228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03556228.